Kremlin comments on US potentially funneling weapons to KievRussian Politics & Diplomacy July 25, 13:45
Kremlin says Russia, US not negotiating renewal of adoptionsRussian Politics & Diplomacy July 25, 13:37
Russian Ice Hockey Federation to render assistance to banned forward ZaripovSport July 25, 13:27
Press review: Malorossiya as an EU taboo and Moldova’s animosity to Russian peacekeepersPress Review July 25, 13:00
Poll reveals most Russians familiar with Jehovah’s Witnesses support its banSociety & Culture July 25, 12:11
Lithuania keeps tipping off NATO allies on Russian-Chinese naval drills in Baltic SeaMilitary & Defense July 25, 12:02
ECHR rules Nemtsov’s convicted murderer should receive 6,000-euro compensationWorld July 25, 11:50
Ukrainian citizen sentenced to community service for wearing St. George ribbonSociety & Culture July 25, 11:04
Top official comments on complications following Siemens refusal to work with state firmsBusiness & Economy July 25, 10:35
MOSCOW, July 12. /TASS/. The first batch of 1,000 Ebola vaccine doses developed at the Gamaleya Research Institute of Epidemiology and Microbiology was sent to the Republic of Guinea on Wednesday, a TASS correspondent reported.
"The first batch of the vaccine is one thousand doses, which means that one thousand people will be vaccinated," said Alexander Semikhin, head of the Biotechnological Products Department at the Gamaleya Institute.
The vaccine is aimed at preventing the fever caused by the Ebola virus. According to Semiklhin, after the vaccination, revaccination is needed in 21 days’ time.
According to the Russian Health Ministry, Russia’s Gam Evac Combi is the world’s first officially registered vaccine approved for clinical use for the prevention of hemorrhagic fever caused by the Ebola virus.
The presentation of the Russian vaccines (named Gam Evac and Gam Evac Combi) to the World Health Organization (WHO) took place in Geneva on February 15.
At a meeting between Russian Health Minister Veronika Skvortsova and WHO Director-General Margaret Chan, the two sides emphasized the importance of the Russian Ebola vaccine for the international community.
According to Skvortsova, the Russian vaccine has proved its effectiveness and has practically no side effects.
"One hundred percent of vaccinated people have a high antibody titer to the causative agent. We have been monitoring the vaccinated individuals for five months now, and this titer has remained high for five months. The blood serum of those vaccinated completely kills and neutralizes the virus in laboratory conditions," the minister explained.